The average one-year price target for Biogen (BIT:1BIIB) has been revised to €182.41 / share. This is a decrease of 26.47% from the prior estimate of €248.09 dated October 21, 2024.

The price target is an average of many targets provided by analysts. The latest targets range from a low of €123.20 to a high of €324.48 / share. The average price target represents an increase of 12.01% from the latest reported closing price of €162.85 / share.

What is the Fund Sentiment?

There are 1,707 funds or institutions reporting positions in Biogen. This is an decrease of 51 owner(s) or 2.90% in the last quarter. Average portfolio weight of all funds dedicated to 1BIIB is 0.18%, an increase of 2.24%. Total shares owned by institutions increased in the last three months by 6.23% to 149,783K shares.

What are Other Shareholders Doing?

Primecap Management holds 16,046K shares representing 10.96% ownership of the company. In its prior filing, the firm reported owning 16,315K shares , representing a decrease of 1.68%. The firm decreased its portfolio allocation in 1BIIB by 18.27% over the last quarter.

VPMCX - Vanguard PRIMECAP Fund Investor Shares holds 9,096K shares representing 6.21% ownership of the company. In its prior filing, the firm reported owning 9,180K shares , representing a decrease of 0.92%. The firm decreased its portfolio allocation in 1BIIB by 17.88% over the last quarter.

Wellington Management Group Llp holds 4,931K shares representing 3.37% ownership of the company. In its prior filing, the firm reported owning 5,131K shares , representing a decrease of 4.07%. The firm decreased its portfolio allocation in 1BIIB by 20.73% over the last quarter.

VGHCX - Vanguard Health Care Fund Investor Shares holds 4,558K shares representing 3.11% ownership of the company. No change in the last quarter.

VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 4,551K shares representing 3.11% ownership of the company. In its prior filing, the firm reported owning 4,621K shares , representing a decrease of 1.53%. The firm decreased its portfolio allocation in 1BIIB by 23.43% over the last quarter.